September 16, 2025: New Possible Lawsuit Option for People Who Experienced Ozempic-Related Vision Loss More medical studies are finding that people who take semaglutide drugs like Ozempic are at an increased risk of a type of blindness caused by NAION (non-arteritic anterior ischemic optic neuropathy)
Suboptimal dosing, insufficient dietary adherence, lack of physical activity, underlying metabolic conditions, or genetic factors affecting GLP-1 sensitivity all influence outcomes
Talk to your healthcare provider if you need help determining what type of physical activity will be safe and effective for you
Your clinician may explain what outcomes are realistic, how quickly effects usually appear, and what signs mean you should seek inperson care instead of continuing online
Pharmacology , 94 (5-6), pp.245-248